Literature DB >> 7800332

Aggressive intrapartum management of lethal fetal anomalies: beyond fetal beneficence.

J A Spinnato1, V D Cook, C R Cook, D H Voss.   

Abstract

OBJECTIVE: To evaluate management recommendations from the current literature for patients whose fetuses are certain to have lethal anomalies or absent (or virtually absent) cognitive function. These recommendations include termination of pregnancy or, for cases in the third trimester, nonaggressive intrapartum management, avoiding cesarean delivery for fetal indications.
METHODS: We report our experience with several patients who voiced opposition to nonaggressive intrapartum care and present a rationale for selectively aggressive, intrapartum management for some of these cases.
RESULTS: Four women whose fetuses had lethal anomalies requested aggressive intrapartum management. For three of the four, standard aggressive management of labor resulted in vaginal delivery of live-born infants who died shortly thereafter. The patients found comfort in the live births. The fourth patient accepted a recommendation to avoid fetal monitoring during labor, and the fetus was stillborn. This patient found the intrapartum experience to be very stressful.
CONCLUSION: When a patient's desire to avoid an intrapartum stillbirth is strong enough that substantial psychological harm might result from one, the physician's beneficence-based obligation to her and respect for maternal autonomy justify selectively aggressive intrapartum therapy, even if no beneficence-based obligation to the fetus exists.

Entities:  

Mesh:

Year:  1995        PMID: 7800332     DOI: 10.1016/0029-7844(94)00310-a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Perinatal management of trisomy 18: a survey of obstetricians in Australia, New Zealand and the UK.

Authors:  D J C Wilkinson; L de Crespigny; C Lees; J Savulescu; P Thiele; T Tran; A Watkins
Journal:  Prenat Diagn       Date:  2013-10-30       Impact factor: 3.050

Review 2.  Ethical language and decision-making for prenatally diagnosed lethal malformations.

Authors:  Dominic Wilkinson; Lachlan de Crespigny; Vicki Xafis
Journal:  Semin Fetal Neonatal Med       Date:  2014-09-05       Impact factor: 3.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.